Laura Forsberg White, PhD
Professor
Boston University School of Public Health
Dept of Biostatistics

PhD, Harvard University



Laura Forsberg White, PhD, is a Professor of Biostatistics at Boston University. She is interested in developing statistical tools to better understand the transmission dynamics and epidemiology of infectious diseases and substance use disorders. She has developed methods to estimate transmission parameters. Her work involves the development of novel methodologies for the detection of disease outbreaks, as well as the application statistical methods for public health surveillance systems, including spatial statistics and time series. Dr. White's work includes applications and collaborations in Tuberculosis, Hepatitis C, HIV, and substance use disorders. She works with several large international studies focused on Tuberculosis and is part of the Boston Providence Center for AIDS Research. She leads her own research group focused on developing statistical methods to better understand TB transmission and burden, as well as Covid-19 transmission dynamics. At SPH, she teaches Public Health Surveillance: A Methods Based Approach (BS 728).

Diversity, Equity, Inclusion and Accessibility

I chair our admissions committee and have participating in holistic admissions workshops. We have modified our processes to be more holistic and also to improve our outreach and support of students from historically underrepresented groups. I have participated in trainings on implicit bias and other topics related to DEIJ.

Adjunct Assistant Professor
Harvard T.H. Chan School of Public Health
Biostatistics




BUSPH Interdisciplinary Training Program for Biostatisticians
07/01/2021 - 06/30/2026 (Multi-PI)
PI: Laura Forsberg White, PhD
NIH/National Institute of General Medical Sciences
5T32GM140972-02

Maximizing Investigator's Research Award (R35)
06/01/2021 - 05/31/2026 (PI)
NIH/National Institute of General Medical Sciences
5R35GM141821-02

Megan Willis (Student Research), Vertex Pharmaceuticals Incorporated
09/30/2022 - 09/29/2023 (PI)
Vertex Pharmaceuticals Incorporated


Tingting Xi (Student Research), Vertex Pharmaceuticals Incorporated
09/30/2022 - 09/29/2023 (PI)
Vertex Pharmaceuticals Incorporated


Researching Effective Strategies to Prevent Opioid Death (RESPOND)
06/01/2018 - 03/31/2023 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA
5R01DA046527-05

Industry Engagement Techdata Corporation RAship for Siwen He
09/01/2020 - 09/01/2022 (PI)
TechData Service Company, LLC


Student Fellowship at Vertex for Xiaoyan Liu
09/01/2021 - 08/31/2022 (PI)
Vertex Pharmaceuticals Incorporated


Biam Institute for Clinical Research RAship for Luke Zheng
09/01/2021 - 08/31/2022 (PI)
Baim Institute for Clinical Research


Methods to estimate the effect of intervention on the incidence and transmission of Tuberculosis
04/15/2017 - 03/31/2022 (PI)
NIH/National Institute of General Medical Sciences
5R01GM122876-05

Vertex Pharmaceuticals Fellowship (Katherine Bloore)
09/01/2019 - 08/31/2021 (PI)
Vertex Pharmaceuticals Incorporated


Showing 10 of 15 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs
2022 BUSPH Interdisciplinary Training Program for Biostatisticians 5T32GM140972-02
2022 Maximizing Investigators' Research Award (R35) 5R35GM141821-02
2021 BUSPH Interdisciplinary Training Program for Biostatisticians 1T32GM140972-01
2021 Maximizing Investigators' Research Award (R35) 1R35GM141821-01
2021 Methods to Estimate the Effect of Interventions on the Incidence and Transmission of Tuberculosis 5R01GM122876-05 3
2020 Methods to Estimate the Effect of Interventions on the Incidence and Transmission of Tuberculosis 5R01GM122876-04 3
2020 Competitive revision to - Methods to estimate the effect of intervention on the incidence and transmission of Tuberculosis 3R01GM122876-04S1 3
2019 Methods to Estimate the Effect of Interventions on the Incidence and Transmission of Tuberculosis 5R01GM122876-03 3
2019 Interdisciplinary Training for Biostatisticians 5T32GM074905-15 104
2018 Methods to Estimate the Effect of Interventions on the Incidence and Transmission of Tuberculosis 5R01GM122876-02 3
Showing 10 of 12 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Barocas JA, Savinkina A, Lodi S, Epstein RL, Bouton TC, Sperring H, Hsu HE, Jacobson KR, Schechter-Perkins EM, Linas BP, White LF. Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study. Clin Infect Dis. 2022 Aug 24; 75(1):e1112-e1119.View Related Profiles. PMID: 34499124; PMCID: PMC8522427; DOI: 10.1093/cid/ciab779;
     
  2. Leavitt SV, Jenkins HE, Sebastiani P, Lee RS, Horsburgh CR, Tibbs AM, White LF. Estimation of the generation interval using pairwise relative transmission probabilities. Biostatistics. 2022 Jul 18; 23(3):807-824.View Related Profiles. PMID: 33527996; PMCID: PMC9291635; DOI: 10.1093/biostatistics/kxaa059;
     
  3. Hall SM, Landaverde L, Gill CJ, Yee GM, Sullivan M, Doucette-Stamm L, Landsberg H, Platt JT, White L, Hamer DH, Klapperich CM. Comparison of anterior nares CT values in asymptomatic and symptomatic individuals diagnosed with SARS-CoV-2 in a university screening program. PLoS One. 2022; 17(7):e0270694.View Related Profiles. PMID: 35830378; PMCID: PMC9278773; DOI: 10.1371/journal.pone.0270694;
     
  4. Bouton TC, Atarere J, Turcinovic J, Seitz S, Sher-Jan C, Gilbert M, White L, Zhou Z, Hossain MM, Overbeck V, Doucette-Stamm L, Platt J, Landsberg HE, Hamer DH, Klapperich C, Jacobson KR, Connor JH. Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study. Clin Infect Dis. 2022 Jun 23.View Related Profiles. PMID: 35737948; PMCID: PMC9278204; DOI: 10.1093/cid/ciac510;
     
  5. Epstein RL, Wang J, White LF, Kapadia SN, Morgan JR, Bao Y, Linas BP. Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured. Am J Prev Med. 2022 Sep; 63(3):e87-e98.View Related Profiles. PMID: 35725599
     
  6. Horsburgh CR, Jo Y, Nichols B, Jenkins HE, Russell CA, White LF. The contribution of reinfection to annual rate of tuberculosis infection (ARI) and incidence of TB disease. Clin Infect Dis. 2022 Jun 06.View Related Profiles. PMID: 35666515; DOI: 10.1093/cid/ciac451;
     
  7. Petros BA, Turcinovic J, Welch NL, White LF, Kolaczyk ED, Bauer MR, Cleary M, Dobbins ST, Doucette-Stamm L, Gore M, Nair P, Nguyen TG, Rose S, Taylor BP, Tsang D, Wendlandt E, Hope M, Platt JT, Jacobson KR, Bouton T, Yune S, Auclair JR, Landaverde L, Klapperich CM, Hamer DH, Hanage WP, MacInnis BL, Sabeti PC, Connor JH, Springer M. Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations. Clin Infect Dis. 2022 May 25.View Related Profiles. PMID: 35616119; PMCID: PMC9213864; DOI: 10.1093/cid/ciac413;
     
  8. Bouton TC, Atarere J, Turcinovic J, Seitz S, Sher-Jan C, Gilbert M, White L, Zhou Z, Hossain MM, Overbeck V, Doucette-Stamm L, Platt J, Landsberg HE, Hamer DH, Klapperich C, Jacobson KR, Connor JH. Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study. medRxiv. 2022 Apr 05.View Related Profiles. PMID: 35411341; PMCID: PMC8996632; DOI: 10.1101/2022.04.04.22273429;
     
  9. Runels T, Ragan EJ, Ventura AS, Winter MR, White LF, Horsburgh CR, Samet JH, Saitz R, Jacobson KR. Testing and treatment for latent tuberculosis infection in people living with HIV and substance dependence: a prospective cohort study. BMJ Open. 2022 03 10; 12(3):e058751.View Related Profiles. PMID: 35273063; PMCID: PMC8915380; DOI: 10.1136/bmjopen-2021-058751;
     
  10. Morgan JR, Quinn EK, Chaisson CE, Ciemins E, Stempniewicz N, White LF, Linas BP, Walley AY, LaRochelle MR. Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design. Med Care. 2022 03 01; 60(3):256-263.View Related Profiles. PMID: 35026792; PMCID: PMC8852217; DOI: 10.1097/MLR.0000000000001689;
     
Showing 10 of 152 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 152 publications over 20 distinct years, with a maximum of 23 publications in 2021

YearPublications
20032
20042
20052
20061
20072
20084
20097
20101
20116
20128
20139
20145
20157
201612
201713
20187
201912
202013
202123
202216
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Biostatistics
Infectious Diseases
infectious Disease Epidemiology
Public Health Surveillance
Tuberculosis
Substance Use Disorders
SARS-CoV-2

I am an experienced mentor of clinical fellows, postdoctoral fellows, PhD students and masters students. I work collaboratively with clinician scientists and provide expertise in statistical modeling, design of studies, and interpretation and dissemination of results. I am committed to meeting mentees where they are and helping them accomplish their personal goals and work through obstacles that they face in their career. I am passionate about seeing the whole person and recognizing the need to strive for appropriate work/life balance.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Education Mentor
  • Project Mentor
  • Research / Scholarly Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


White's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department